Abstract:Abstract:ObjectiveTo investigate the expression of Fra1 (Fosrelated antigen1) and Fra2 (Fosrelated antigen2) in laryngeal squamous carcinoma cell ( LSCC ), as well as their correlation.MethodsProtein expression and mRNA expression of Fra1 and Fra2 were detected by SP immunohistochemistry and reverse transcription polymerase chain reaction (RTPCR) in 47 LSCC tissues and 21 normal adjacent tissues. The relations between the expression of the two genes as well as those between them and clinicopathological parameters in tumor tissue were analyzed.ResultsThe positive expression rates of Fra1 and Fra2 protein in LSCC were both higher than those in the normal adjacent tissues (both P<0.05). Their protein expression levels in LSCC were associated with clinical stage, lymph node metastasis and smoking, but not associated with pathological grade and anatomic site of tumor, or patients’ age. The expression levels of mRNA of Fra1 and Fra2 in LSCC were higher than those in the normal adjacent tissues (both P<0.01). The mRNA expression of Fra1 was related to clinical stage, pathological grade, lymph node metastasis and smoking, but not related to patients’ age and anatomic site of tumor. The mRNA expression of Fra2 was not associated with all the parameters except for pathological grade. In addition, linear correlation analysis revealed positive correlation between the mRNA expression of Fra1 and Fra2 (r=0.570, P<0.01).ConclusionsThe expression of Fra1 and Fra2 in LSCC is increased at both mRNA and protein levels, and the expression products of Fra1 and Fra2 are positively correlated. The two genes may activate with each other to promote the development and progression of LSCC.